Lucence, DXD Hub, and NCCS launch $6m UNITED 2.0 cancer test

The team will adopt a dual WES-WTS approach for more detailed tumour profiling.

Lucence, Diagnostics Development Hub hosted by A*STAR, and the National Cancer Centre Singapore have launched UNITED 2.0, a $6m research collaboration to develop a next-generation, clinical-grade cancer profiling test.

The initiative builds on the original UNITED 1.0 tissue test, which analysed tumour and tissue samples across 572 genes and 71 RNA fusions using both DNA and RNA signals.

UNITED 2.0 will adopt a dual whole-exome sequencing and whole transcriptome sequencing approach to provide more detailed tumour profiling.

The team will also use artificial intelligence to streamline the analysis and reporting of the genomic data generated.

The clinical-grade test will cover a broad range of cancers, including breast, lung, colon, bladder, CNS tumours, and lymphoma.

The collaboration also plans to develop post-treatment monitoring tools, including minimal residual disease testing to detect early signs of cancer recurrence.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia